The test is particularly useful in cases of a subtype of lung cancer called thenon-small cell lung cancer(NSCLC) type adenocarcinoma.The blood test is based on a simple principle: the cancer cells release a specific mutated deoxyribonucleic acid or DNA (genetic material) into the blood; this ...
This type of lung cancer is associated with 80 percent of diagnosed lung cancers. The team was headed by Li Zhong, an assistant professor in the Division of Pulmonary, Critical Care and Sleep Medicine of the medical center. This blood test employs a group of five cancer-related protein ...
The findings could lead to ablood testfor lung cancer, according to a researcher with the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute who helped lead study. "We found patterns of abnormal microRNAs in the plasma o...
Testing solutionsSpanning the Lung Cancer Continuum of Care Access fast, reliable, and actionable biological insights with our genomic and proteomic tests to gain a deeper understanding of each patient’s disease state, help expedite diagnosis, and guide confident treatment decisions. ...
miR-Test: A Blood Test for Lung Cancer Early Detection Lung cancer is the leading cause of cancer death worldwide. Low-dose computed tomography screening (LDCT) was recently shown to anticipate the time of diagnosis, thus reducing lung cancer mortality. However, concerns persist about the fe.....
Testing for the presence of specific cancer protein 'fingerprints' in the blood of lung cancer patients may be a useful means of identifying a subgroup whose tumors are more likely to shrink when treated with the drug erlotinib, especially when other testing meth...
JERUSALEM, Oct. 13 (Xinhua) -- Israeli researchers have found a method for detecting lung cancer risk by examining the patient's DNA using a simple blood test, the Weizmann Institute of Science (WIS) said Sunday. In a study published in the Journal of the National Cancer Institute-Cancer ...
What if a less expensive and more easily administered test could refine who is at highest risk for lung cancer, and therefore identify the top candidates for LDCT? A team of Italian researchers believe they have developed such a tool — an experimental blood test that detects genetic material ...
Testing solutionsSpanning the Lung Cancer Continuum of Care Access fast, reliable, and actionable biological insights with our genomic and proteomic tests to gain a deeper understanding of each patient’s disease state, help expedite diagnosis, and guide confident treatment decisions. ...
"A test like this could be a first screen to determine whether someone has lung cancer, then could actually go on to the next level of examination," said Showe. "It's wonderful, and I really hope it works," said Julie. The lung cancer blood test would mean there would be more patie...